BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33052724
Number of visits today
4853
Number of downloads
16252035
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: van der Schrier R, Dahan JDC, Boon M, Sarton E, van Velzen M, Niesters M, Dahan A. Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity. Anesthesiology 2021. [PMID: 34958670 DOI: 10.1097/ALN.0000000000004096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Razlansari M, Ulucan-Karnak F, Kahrizi M, Mirinejad S, Sargazi S, Mishra S, Rahdar A, Díez-Pascual AM. Nanobiosensors for detection of opioids: A review of latest advancements. Eur J Pharm Biopharm 2022:S0939-6411(22)00182-5. [PMID: 36067954 DOI: 10.1016/j.ejpb.2022.08.017] [Reference Citation Analysis]
2 Algera MH, Cotten JF, van Velzen M, Niesters M, Boon M, Shoham DS, Dandrea KE, van der Schrier R, Dahan A. Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression? Pharmacol Res Perspect 2022;10:e00974. [PMID: 35621218 DOI: 10.1002/prp2.974] [Reference Citation Analysis]
3 Algera MH, Cotten JF, van Velzen M, Niesters M, Boon M, Shoham DS, Dandrea KE, van der Schrier R, Dahan A. Respiratory effects of thyrotropin-releasing hormone and its analogue taltirelin on opioid-induced respiratory depression. Br J Anaesth 2022:S0007-0912(22)00147-7. [PMID: 35459532 DOI: 10.1016/j.bja.2022.03.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345